S&P 500   0.52 (-8.53%)
DOW   0.52 (-8.53%)
QQQ   270.38 (+0.37%)
AAPL   438.66 (+0.67%)
MSFT   213.29 (-1.50%)
FB   249.83 (-0.85%)
GOOGL   1,473.30 (-0.64%)
AMZN   3,138.83 (+0.87%)
NVDA   449.11 (+1.98%)
CGC   19.32 (+1.36%)
BABA   262.20 (+1.65%)
TSLA   1,487.00 (+0.13%)
MU   51.30 (+1.81%)
GE   6.14 (+0.49%)
AMD   85.04 (+9.49%)
T   30.01 (+1.32%)
F   6.86 (+2.54%)
ACB   10.73 (+2.98%)
GILD   70.88 (-1.18%)
NFLX   509.64 (+2.21%)
DIS   117.29 (+0.81%)
BAC   25.01 (+0.08%)
BA   165.07 (+1.73%)
S&P 500   0.52 (-8.53%)
DOW   0.52 (-8.53%)
QQQ   270.38 (+0.37%)
AAPL   438.66 (+0.67%)
MSFT   213.29 (-1.50%)
FB   249.83 (-0.85%)
GOOGL   1,473.30 (-0.64%)
AMZN   3,138.83 (+0.87%)
NVDA   449.11 (+1.98%)
CGC   19.32 (+1.36%)
BABA   262.20 (+1.65%)
TSLA   1,487.00 (+0.13%)
MU   51.30 (+1.81%)
GE   6.14 (+0.49%)
AMD   85.04 (+9.49%)
T   30.01 (+1.32%)
F   6.86 (+2.54%)
ACB   10.73 (+2.98%)
GILD   70.88 (-1.18%)
NFLX   509.64 (+2.21%)
DIS   117.29 (+0.81%)
BAC   25.01 (+0.08%)
BA   165.07 (+1.73%)
S&P 500   0.52 (-8.53%)
DOW   0.52 (-8.53%)
QQQ   270.38 (+0.37%)
AAPL   438.66 (+0.67%)
MSFT   213.29 (-1.50%)
FB   249.83 (-0.85%)
GOOGL   1,473.30 (-0.64%)
AMZN   3,138.83 (+0.87%)
NVDA   449.11 (+1.98%)
CGC   19.32 (+1.36%)
BABA   262.20 (+1.65%)
TSLA   1,487.00 (+0.13%)
MU   51.30 (+1.81%)
GE   6.14 (+0.49%)
AMD   85.04 (+9.49%)
T   30.01 (+1.32%)
F   6.86 (+2.54%)
ACB   10.73 (+2.98%)
GILD   70.88 (-1.18%)
NFLX   509.64 (+2.21%)
DIS   117.29 (+0.81%)
BAC   25.01 (+0.08%)
BA   165.07 (+1.73%)
S&P 500   0.52 (-8.53%)
DOW   0.52 (-8.53%)
QQQ   270.38 (+0.37%)
AAPL   438.66 (+0.67%)
MSFT   213.29 (-1.50%)
FB   249.83 (-0.85%)
GOOGL   1,473.30 (-0.64%)
AMZN   3,138.83 (+0.87%)
NVDA   449.11 (+1.98%)
CGC   19.32 (+1.36%)
BABA   262.20 (+1.65%)
TSLA   1,487.00 (+0.13%)
MU   51.30 (+1.81%)
GE   6.14 (+0.49%)
AMD   85.04 (+9.49%)
T   30.01 (+1.32%)
F   6.86 (+2.54%)
ACB   10.73 (+2.98%)
GILD   70.88 (-1.18%)
NFLX   509.64 (+2.21%)
DIS   117.29 (+0.81%)
BAC   25.01 (+0.08%)
BA   165.07 (+1.73%)
Log in

NASDAQ:MDRXAllscripts Healthcare Solutions Stock Price, Forecast & News

$8.79
-0.50 (-5.38 %)
(As of 08/4/2020 04:00 PM ET)
Add
Compare
Today's Range
$8.76
Now: $8.79
$9.39
50-Day Range
$6.22
MA: $7.02
$9.29
52-Week Range
$4.56
Now: $8.79
$11.82
Volume2.15 million shs
Average Volume2.34 million shs
Market Capitalization$1.43 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.1
Allscripts Healthcare Solutions, Inc. provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), connectivity, private cloud hosting, outsourcing, analytics, patient engagement, clinical decision support, and population health management solutions. The company operates in two segments, Clinical and Financial Solutions and Population Health. The Clinical and Financial Solutions segment provides integrated clinical software applications and financial and information solutions, which primarily include EHR-related software, connectivity and coordinated care solutions, and financial and practice management software solutions, as well as related installation, support and maintenance, outsourcing, private cloud hosting, revenue cycle management, training, and electronic claims administration services. The Population Health segment offers health management, and financial management and patient engagement solutions to hospitals, health systems, accountable care organizations, and other care facilities. The company serves physicians, hospitals, governments, health systems, health plans, life-sciences companies, retail clinics, retail pharmacies, pharmacy benefit managers, insurance companies, and employer wellness clinics, as well as post-acute organizations, such as home health and hospice agencies. Allscripts Healthcare Solutions, Inc. was founded in 1986 and is headquartered in Chicago, Illinois.
Read More
Allscripts Healthcare Solutions logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.14 out of 5 stars


Industry, Sector and Symbol

Industry Computer integrated systems design
Sub-IndustryHealth Care Technology
SectorMedical
Current SymbolNASDAQ:MDRX
CUSIP01988P10
Phone800-334-8534

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.77 billion
Cash Flow$2.01 per share
Book Value$7.92 per share

Profitability

Net Income$-182,180,000.00

Miscellaneous

Employees9,600
Market Cap$1.43 billion
Next Earnings Date11/2/2020 (Estimated)
OptionableOptionable
$8.79
-0.50 (-5.38 %)
(As of 08/4/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MDRX News and Ratings via Email

Sign-up to receive the latest news and ratings for MDRX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Allscripts Healthcare Solutions (NASDAQ:MDRX) Frequently Asked Questions

How has Allscripts Healthcare Solutions' stock been impacted by COVID-19 (Coronavirus)?

Allscripts Healthcare Solutions' stock was trading at $6.31 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, MDRX stock has increased by 39.3% and is now trading at $8.79.
View which stocks have been most impacted by Coronavirus
.

Do Wall Street analysts recommend investors buy shares of Allscripts Healthcare Solutions?

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Allscripts Healthcare Solutions in the last year. There are currently 3 sell ratings, 7 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Allscripts Healthcare Solutions
.

When is Allscripts Healthcare Solutions' next earnings date?

Allscripts Healthcare Solutions is scheduled to release its next quarterly earnings announcement on Monday, November 2nd 2020.
View our earnings forecast for Allscripts Healthcare Solutions
.

How were Allscripts Healthcare Solutions' earnings last quarter?

Allscripts Healthcare Solutions Inc (NASDAQ:MDRX) released its quarterly earnings results on Thursday, July, 30th. The software maker reported $0.18 EPS for the quarter, beating the Zacks' consensus estimate of $0.08 by $0.10. The software maker had revenue of $406.20 million for the quarter, compared to analysts' expectations of $399.80 million. Allscripts Healthcare Solutions had a positive return on equity of 5.55% and a negative net margin of 3.06%.
View Allscripts Healthcare Solutions' earnings history
.

What price target have analysts set for MDRX?

14 analysts have issued 1 year price targets for Allscripts Healthcare Solutions' stock. Their forecasts range from $5.50 to $13.00. On average, they expect Allscripts Healthcare Solutions' stock price to reach $8.93 in the next year. This suggests a possible upside of 1.6% from the stock's current price.
View analysts' price targets for Allscripts Healthcare Solutions
.

Has Allscripts Healthcare Solutions been receiving favorable news coverage?

News stories about MDRX stock have been trending somewhat positive on Tuesday, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Allscripts Healthcare Solutions earned a daily sentiment score of 0.8 on InfoTrie's scale. They also assigned news headlines about the software maker a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the company's share price in the near future.
View the latest news about Allscripts Healthcare Solutions
.

Who are some of Allscripts Healthcare Solutions' key competitors?

What other stocks do shareholders of Allscripts Healthcare Solutions own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Allscripts Healthcare Solutions investors own include Advanced Micro Devices (AMD), Netflix (NFLX), Walgreens Boots Alliance (WBA), Starbucks (SBUX), Activision Blizzard (ATVI), CVS Health (CVS), Ford Motor (F), Intel (INTC), Nuance Communications (NUAN) and Oasis Petroleum (OAS).

Who are Allscripts Healthcare Solutions' key executives?

Allscripts Healthcare Solutions' management team includes the following people:
  • Mr. Paul M. Black, CEO & Director (Age 61)
  • Mr. Richard J. Poulton, Pres (Age 54)
  • Mr. Dennis M. Olis, Chief Financial Officer (Age 56)
  • Mr. Brian P. Farley, Exec. VP, Gen. Counsel, Corp. Sec. & Chief Admin. Officer (Age 49)
  • Ms. Lisa Khorey, Exec. VP & Chief Client Delivery Officer (Age 52)

What is Allscripts Healthcare Solutions' stock symbol?

Allscripts Healthcare Solutions trades on the NASDAQ under the ticker symbol "MDRX."

Who are Allscripts Healthcare Solutions' major shareholders?

Allscripts Healthcare Solutions' stock is owned by a number of retail and institutional investors. Top institutional investors include Paradigm Capital Management Inc. NY (1.01%), Peregrine Capital Management LLC (0.82%), Smith Graham & Co. Investment Advisors LP (0.72%), North Star Asset Management Inc. (0.45%), New York State Teachers Retirement System (0.23%) and Comerica Bank (0.13%). Company insiders that own Allscripts Healthcare Solutions stock include Brian Farley, Dennis Olis, Lisa Khorey, Mara G Aspinall, Paul Black, Richard J Poulton and Yancey L Spruill.
View institutional ownership trends for Allscripts Healthcare Solutions
.

Which major investors are selling Allscripts Healthcare Solutions stock?

MDRX stock was sold by a variety of institutional investors in the last quarter, including Peregrine Capital Management LLC, SG Americas Securities LLC, North Star Asset Management Inc., UBS Group AG, Texas Permanent School Fund, Zeke Capital Advisors LLC, and Arizona State Retirement System. Company insiders that have sold Allscripts Healthcare Solutions company stock in the last year include Brian Farley, Dennis Olis, and Lisa Khorey.
View insider buying and selling activity for Allscripts Healthcare Solutions
.

Which major investors are buying Allscripts Healthcare Solutions stock?

MDRX stock was purchased by a variety of institutional investors in the last quarter, including Smith Graham & Co. Investment Advisors LP, Paradigm Capital Management Inc. NY, Comerica Bank, New York State Teachers Retirement System, Oregon Public Employees Retirement Fund, CIBC Asset Management Inc, First Quadrant L P CA, and Profund Advisors LLC. Company insiders that have bought Allscripts Healthcare Solutions stock in the last two years include Mara G Aspinall, Paul Black, Richard J Poulton, and Yancey L Spruill.
View insider buying and selling activity for Allscripts Healthcare Solutions
.

How do I buy shares of Allscripts Healthcare Solutions?

Shares of MDRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Allscripts Healthcare Solutions' stock price today?

One share of MDRX stock can currently be purchased for approximately $8.79.

How big of a company is Allscripts Healthcare Solutions?

Allscripts Healthcare Solutions has a market capitalization of $1.43 billion and generates $1.77 billion in revenue each year. The software maker earns $-182,180,000.00 in net income (profit) each year or $0.47 on an earnings per share basis. Allscripts Healthcare Solutions employs 9,600 workers across the globe.

What is Allscripts Healthcare Solutions' official website?

The official website for Allscripts Healthcare Solutions is www.allscripts.com.

How can I contact Allscripts Healthcare Solutions?

Allscripts Healthcare Solutions' mailing address is 222 MERCHANDISE MART PLAZA SUITE 2024, CHICAGO IL, 60654. The software maker can be reached via phone at 800-334-8534 or via email at [email protected]

This page was last updated on 8/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.